This bill has overwhelming support from the New York Senate and Assembly as well as the people of New York. The people of New York have spoken and spoken loudly. Too many pharmacies have been forced to close. Governor Kathy Hochul please sign this bill into law sooner than later.

This bill has overwhelming support from the New York Senate and Assembly as well as the people of New York. The people of New York have spoken and spoken loudly. Too many pharmacies have been forced to close. Governor Kathy Hochul please sign this bill into law sooner than later.

@NYS_AM what is going on with A5882c? 121/150 members have signed on as cosponsors, it deserves a vote! Don’t let PCMA stop you from protecting patient access to pharmacy care in communities across New York. #FixRx

Tell Your Assemblymember: Pass PAPA Before Session Ends votervoice.net/Shares/BXA3CB…

The Patients Before Monopolies Act eliminates the vertical integration between Pharmacy Benefit Managers (PBMs) and pharmacy businesses. nyrxlaw.com/blog/?post_id=5&…

The Patient Access to Pharmacy Act (PAPA) is legislation aimed at protecting patient access to community pharmacies across New York by reforming how Pharmacy Benefit Managers (PBMs) reimburse pharmacies. The bill would establish a fairer and more transparent “cost-plus” reimbursement model to stop PBMs from paying pharmacies below the cost of acquiring and dispensing medications, helping independent and neighborhood pharmacies remain open and continue serving patients. PAPA has earned overwhelming bipartisan support in the New York State Assembly, with 112 Assembly Member sponsors backing the bill, yet despite this strong support, it still has not been called to the Assembly floor for a vote. With pharmacies continuing to close across the state and the legislative session running out of time, supporters are confused as to why the bill still sits stagnant in the Assembly. Lawmakers must act now before more patients lose access to their local pharmacy care.

He also appears to be blocking the Patient Access to Pharmacy Act #PAPA as well which has 112 Assembly Member cosponsors. Out of the way: Legislature must pass Super Speeders bill speedily nydailynews.com/2026/04/26/o…

New simplistic look and user-friendly search bar. nyrxlaw.com

The PBM lobby is pulling out all the stops to kill vertical integration reform in Tennessee. They've already spent $7 million. 💸 🔎 Read more: bit.ly/4sGTLRV

It's been almost a year since this article was published and the #PAPA bill still sits in the NYS Assembly ! For the future of New York’s healthcare system, it’s crucial to pass The Patient Access to Pharmacy Act - EMPIRE REPORT NEW YORK 2026® NEW YORK'S 24/7 NEWS SITE empirereportnewyork.com/for-…

I know CVS loves making “S.O.S.” signs, so I asked @grok to make one up for the independent pharmacy owners.

Speaker White removes Rep. Hobgood-Wilkes as committee chair over her advocacy for PBM reform mississippitoday.org/2025/06…

When Standard Oil controlled the flow of energy, it didn’t just compete—it decided who could access the market. When AT&T dominated telecommunications, it didn’t just provide service—it controlled who could connect.   And today, pharmacy benefit managers—companies like CVS Caremark, Express Scripts, and OptumRx—have taken on a similar role in healthcare.   They don’t manufacture medications. They don’t prescribe them.   But they decide which drugs patients can access… where they can get them… and at what cost.   This isn’t just about competition. It’s about control.   History shows us what happens when too much power is concentrated in too few hands—we act.   And for the sake of patients and the pharmacies that serve them, it’s time to take a hard look again.

Don’t do nothing ! Protect Access to Pharmacies for State Employees and Communities: Click on the link and send a message to your elected officials today! pssny.org/votervoice

🚨 A new lawsuit alleges CVS Caremark inflated the cost of generic drugs, charging patients and employers far more than the actual price. This isn't the first time we've heard this, and it won't be the last. bit.ly/3NSu8zn